Svensk version
Home
Patients & Public
PATIENTS & PUBLIC
THERAPY AREAS
MEDICAL CONTACTS
PATIENT ORGANIZATIONS
ORDERING PRODUCTS
OUR WEBSITES
Healthcare Professionals
HEALTHCARE PROFESSIONALS
PRODUCTS BY THERAPY AREA
PRODUCTS ALPHABETICAL LIST
MEDICAL CONTACTS
ORDERING PRODUCTS
OUR AFFILIATES & HEADQUARTERS
OUR WEBSITES
PRODUCT PIPELINE
PATIENT FOCUS
DEVELOPMENT PIPELINE
PRODUCT SUPPLY
BUSINESS DEVELOPMENT
PARTNERING
Investors & Media
INVESTORS & MEDIA
INTERIM & ANNUAL REPORTS
PRESENTATIONS
WEB & AUDIO CASTS
FINANCIAL CALENDAR
SHARE INFORMATION
PRESS RELEASES & NEWS
CORPORATE GOVERNANCE
BOARD OF DIRECTORS
SENIOR MANGEMENT
IMAGE BANK
RIGHTS ISSUE
CAPITAL MARKETS SEMINAR
About us
OUR COMPANY
VISION
MISSION & VALUES
WHY FOCUS ON RARE DISEASES
CORPORATE RESPONSIBILITY
BOARD OF DIRECTORS
SENIOR MANAGEMENT
CORPORATE GOVERNANCE
CAREERS
ALL CONTACTS
CALENDAR
You are here:
Start
|
Investors & Media
|
PRESS RELEASES & NEWS
INVESTORS & MEDIA
INTERIM & ANNUAL REPORTS
PRESENTATIONS
WEB & AUDIO CASTS
FINANCIAL CALENDAR
SHARE INFORMATION
PRESS RELEASES & NEWS
CORPORATE GOVERNANCE
BOARD OF DIRECTORS
SENIOR MANGEMENT
IMAGE BANK
RIGHTS ISSUE
CAPITAL MARKETS SEMINAR
Press Releases & News
Select year
2012-04-26 19:30
Sobi:Resolutions from Swedish Orphan Biovitrum's ("Sobi") Annual General Meeting (AGM)
2012-04-26 08:30
Sobi : Interim Report, January - March 2012
2012-04-24 08:52
Sobi: The board of directors exercises authorization for share issuance and repurchase of shares
2012-04-17 16:16
Sobi: Invitation - Presentation of first quarter results
2012-04-05 20:00
Sobi's Annual Report published on the web
2012-03-30 08:30
Sobi amends its agreement with sellers of Arexis AB
2012-03-26 08:30
Notice of annual general meeting in Swedish Orphan Biovitrum AB (publ)
2012-03-20 12:15
CFO Lars Sandström to leave Sobi
2012-02-23 08:30
Sobi: Report for the Fourth Quarter and Full Year 2011
2012-02-17 17:15
Sobi: Presentation of Q4 and Full Year 2011 results
More Press releases
Select year
2012-04-18 16:18
Inform Genomics Announces Results of Study Predicting Risk of Oral Mucositis in Patients Undergoing High Dose Chemotherapy
2012-01-09 15:06
Gentium Appoints Swedish Orphan Biovitrum AB as Exclusive Distributor of Defibrotide in Nordic and Baltic Territories
2011-08-29 10:58
Pharming grants Sobi additional territories for the commercialization of Ruconest®
2011-01-27 13:06
Fresenius Biotech announcement regarding the agreement with Swedish Orphan Biovitrum for distribution of Removab®
2011-01-26 09:23
Sobi and Biogen Idec Hemophilia host symposium at EAHAD
2010-10-28 18:58
Pharming’s Ruconest™ For HAE Granted European Marketing Authorization
2010-11-29 11:48
Pharming Announces Topline Study Results On Prophylactic Use Of Ruconest In Hereditary Angioedema
2010-12-28 09:24
Swedish Orphan Biovitrum and Pharming Announce First Sales of Ruconest in Europe
More news